Cov cuab yeej siv Biochemical yog qhov tseem ceeb hauv kev kuaj mob niaj hnub, kev soj ntsuam mob, kho mob, thiab kev soj ntsuam kev noj qab haus huv. Kev nce qib hauv biotechnology thiab cov ntaub ntawv kev tshawb fawb tau txhim kho cov rhiab, muaj feem cuam tshuam nrog cov ntaub ntawv kev txhawb nqa rau cov tshuaj kho mob.
Kev siv tshuaj lom yog feem ntau siv los ntsuas cov ntshav hauv lub cev xws li ntshav, ntshav ua haujlwm, thiab raum muaj nuj nqi. Cov teeb meem no xav txog lub cev metabolic xeev thiab cov kev ua haujlwm hauv lub cev, pab cov kws kho mob ntsuas tus mob thiab kev kho mob ntsuas tus mob. Piv txwv li, cov cuab yeej muaj ntshav zoo yog cov cuab yeej tseem ceeb rau cov kev tswj hwm ntshav qab zib, thaum muaj kev paub txog thaum ntxov ntawm kev kuaj mob myocardial me ntsis.
Los ntawm kev xam pom txuj ci, kev txhim kho biochemical kev ua haujlwm tau hloov zuj zus los ntawm cov tshuaj pleev xim tsoos (ELISSAS), thiab tam sim no kom meej) Early assays relied on simple chemical reactions, such as color changes, to qualitatively or semi-quantitatively detect target substances. Kev ntsuam xyuas niaj hnub no sib xyaw ua ke xws li enzyme catalyning, thiab kev txhim kho fluorension, txhim kho kev pom tseeb thiab rhiab. Piv txwv li, chemiluminescent reagents siv cov ntsiab lus ntawm biomarkers uas tsis muaj txiaj ntsig zoo, ua rau lawv pom tias muaj mob qog qog nqaij hlav cancer.
Hauv kev thov kho mob, txheej txheem qauv thiab ua ntu zus ntawm cov reagents yog qhov tseem ceeb heev. Vim tias kev kuaj cov txiaj ntsig yuav txawv ntawm cov chaw tsim khoom sib txawv) muaj cov qauv kev kawm nruj (xws li cov qauv kev ua tau zoo hauv tebchaws (xws li cov qauv kev ua tau zoo hauv ntiaj teb Tsis tas li ntawd, kev siv dav dav siv ntawm cov khoom siv kuaj ntsuas hauv qhov kev sim ua ntxiv. Piv txwv li, tag nrho cov neeg ntsuam xyuas cov neeg txheeb xyuas biochemical tuaj yeem ua tiav cov kev xeem hauv feeb, ntsib kev ntsuas kub- theb yuav tsum tau.
In the future, the development trend of biochemical testing reagents will focus on micro-sample testing, multi-indicator testing, and point-of-care testing (POCT). Kev sib xyaw ntawm microfluidic nti thev naus laus zis thiab cov khoom kuaj cov neeg ua haujlwm tau kuaj xyuas hauv tsev lossis kev txhim kho cov tshuaj kho mob hauv zej zog thiab kev tswj hwm tus kheej. Tsis tas li ntawd, kev txawj ntse yuam kev thiab cov ntaub ntawv pov thawj loj yuav ua kom pom kev txhais cov ntaub ntawv thiab pab cov kev txiav txim siab hauv kev tiv thaiv {}}} kev txiav txim siab.
Hauv ntej, raws li cov cuab yeej kuaj mob hauv kev kho mob, cov reagents kev kho mob txuas ntxiv tsav kev txhim kho hauv kev paub txog kab mob thiab kev kho mob los ntawm kev tsim kho thev naus laus zis. Nrog rau hauv - kev loj hlob ntawm cov tshuaj kho mob, biochemical ntsuas reagents yuav ua lub luag haujlwm ntawm kev tiv thaiv kab mob ntau, kev kuaj mob, thiab kev kho mob.